Glenmark Pharmaceuticals Limited (GLENMARK) — Board Meeting | 13 August 2026
Glenmark Pharmaceuticals announced its 48th AGM on September 11, 2026, via video conferencing, where shareholders will vote on approving FY2025-26 financial statements, declaring a dividend of INR 2.50 per share, and reappointing Non-Executive Director Mrs. Blanche Saldanha, an 86-year-old promoter-linked figure with 0.39% direct shareholding. The meeting, scheduled for 14:00 IST, requires e-voting between September 8-10, with record date August 31, 2026, and dividend payment on September 14. Shareholders must ensure PAN-Aadhaar compliance and update KYC details to claim dividends or participate electronically.
About Glenmark Pharmaceuticals Limited (GLENMARK)
Healthcare · Pharmaceuticals · Listed on NSE
📡 Get AI alerts when GLENMARK files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track GLENMARK — Free💡 Ask AI about this filing
📊 More GLENMARK filings
- 🔴 Announcement — 11 September 2026 Glenmark Pharmaceuticals announced the launch of RYALTRIS Nasal Spray in Brazil for allergic rhiniti...
- 🟡 Board Meeting — 11 September 2026 Glenmark Pharmaceuticals held its 48th AGM on September 11, 2026 via video conferencing, where share...
- 🟡 Voting Results — 11 September 2026 Glenmark Pharmaceuticals held its 48th AGM on September 11, 2026 via video conference, approving aud...
- 🔴 Announcement — 11 September 2026 India Ratings upgraded Glenmark Pharmaceuticals' long-term bank loans to IND AA+ from IND AA with a ...
- Announcement — 20 August 2026 Glenmark Pharmaceuticals announced U.S. FDA approval for its generic Fluticasone Propionate Nasal Sp...
🔥 Also filed on 13 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when GLENMARK files new disclosures
Track GLENMARK filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track GLENMARK — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research
About · Privacy Policy · Terms of Service · Pricing
Today's Announcements · Screener · Insights · AI Chat
Data provided by CMOTS Internet Technologies Pvt Ltd